isopharm limited

2

isopharm limited Company Information

Share ISOPHARM LIMITED
Live 
MatureMid

Company Number

03843619

Registered Address

unit 18 jessops riverside, 800 brightside lane, sheffield, S9 2RX

Industry

Manufacture of medical and dental instruments and supplies

 

Telephone

01709525256

Next Accounts Due

December 2024

Group Structure

View All

Directors

Paul Ward5 Years

Neil Laycock0 Years

View All

Shareholders

agilo software bidco limited 100%

isopharm limited Estimated Valuation

£6m

Pomanda estimates the enterprise value of ISOPHARM LIMITED at £6m based on a Turnover of £5.6m and 1.08x industry multiple (adjusted for size and gross margin).

isopharm limited Estimated Valuation

£0

Pomanda estimates the enterprise value of ISOPHARM LIMITED at £0 based on an EBITDA of £-197k and a 6.28x industry multiple (adjusted for size and gross margin).

isopharm limited Estimated Valuation

£1.4m

Pomanda estimates the enterprise value of ISOPHARM LIMITED at £1.4m based on Net Assets of £648k and 2.21x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Isopharm Limited Overview

Isopharm Limited is a live company located in sheffield, S9 2RX with a Companies House number of 03843619. It operates in the manufacture of medical and dental instruments and supplies sector, SIC Code 32500. Founded in September 1999, it's largest shareholder is agilo software bidco limited with a 100% stake. Isopharm Limited is a mature, mid sized company, Pomanda has estimated its turnover at £5.6m with unknown growth in recent years.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

Isopharm Limited Health Check

Pomanda's financial health check has awarded Isopharm Limited a 2 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 5 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating2out of 5
positive_score

1 Strong

positive_score

5 Regular

positive_score

5 Weak

size

Size

annual sales of £5.6m, make it smaller than the average company (£16.4m)

£5.6m - Isopharm Limited

£16.4m - Industry AVG

growth

Growth

There is insufficient data available for this Key Performance Indicator!

- - Isopharm Limited

- - Industry AVG

production

Production

with a gross margin of 39.3%, this company has a comparable cost of product (38.2%)

39.3% - Isopharm Limited

38.2% - Industry AVG

profitability

Profitability

an operating margin of -7.9% make it less profitable than the average company (6.3%)

-7.9% - Isopharm Limited

6.3% - Industry AVG

employees

Employees

with 57 employees, this is below the industry average (87)

57 - Isopharm Limited

87 - Industry AVG

paystructure

Pay Structure

on an average salary of £37.2k, the company has an equivalent pay structure (£45.2k)

£37.2k - Isopharm Limited

£45.2k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £97.6k, this is less efficient (£173.4k)

£97.6k - Isopharm Limited

£173.4k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 57 days, this is near the average (48 days)

57 days - Isopharm Limited

48 days - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 39 days, this is close to average (39 days)

39 days - Isopharm Limited

39 days - Industry AVG

stockdays

Stock Days

it holds stock equivalent to 46 days, this is less than average (98 days)

46 days - Isopharm Limited

98 days - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 17 weeks, this is average cash available to meet short term requirements (15 weeks)

17 weeks - Isopharm Limited

15 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 73.8%, this is a higher level of debt than the average (43.1%)

73.8% - Isopharm Limited

43.1% - Industry AVG

ISOPHARM LIMITED financials

EXPORTms excel logo

Isopharm Limited's latest turnover from March 2023 is £5.6 million and the company has net assets of £648 thousand. According to their latest financial statements, Isopharm Limited has 57 employees and maintains cash reserves of £608 thousand as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Mar 2023Mar 2022Mar 2021Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Mar 2010
Turnover5,565,0005,356,0005,771,0003,810,0002,568,5842,146,8231,822,8031,732,000738,269747,368653,9241,290,2291,406,4351,839,971
Other Income Or Grants00000000000000
Cost Of Sales3,377,0002,928,0003,131,0001,634,0001,560,8141,292,9301,061,825990,463429,250445,547387,948759,248824,3631,052,564
Gross Profit2,188,0002,428,0002,640,0002,176,0001,007,769853,892760,978741,537309,019301,821265,976530,980582,072787,407
Admin Expenses2,626,0001,910,0002,459,0001,905,000709,439779,417658,179534,108291,363257,963210,438531,133582,198787,755
Operating Profit-438,000518,000181,000271,000298,33074,475102,799207,42917,65643,85855,538-153-126-348
Interest Payable006,0005,0005,9473,9709080000000
Interest Receivable1,000001,0002,1911,053424519394292151153126348
Pre-Tax Profit-437,000518,000175,000267,000294,57471,558102,315207,94818,05144,14955,689000
Tax-25,00060,00029,000-96,000-55,969-13,596-20,463-41,589-3,791-10,154-13,365000
Profit After Tax-462,000578,000204,000171,000238,60557,96281,852166,35814,26033,99542,324000
Dividends Paid0016,00051,0000000000000
Retained Profit-462,000578,000188,000120,000238,60557,96281,852166,35814,26033,99542,324000
Employee Costs2,120,0001,621,0001,916,000946,0001,210,244813,721720,545595,135229,631223,051216,326393,090423,584527,076
Number Of Employees5750443629201815666111216
EBITDA*-197,000815,000535,000491,000302,21576,241105,300234,53343,97566,45162,3012,6711,70052,436

* Earnings Before Interest, Tax, Depreciation and Amortisation

Mar 2023Mar 2022Mar 2021Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Mar 2010
Tangible Assets183,000477,00097,000431,000344,289356,346136,529109,93127,72847,78554,3623,6605,6985,141
Intangible Assets00386,00000000000000
Investments & Other00000000000000
Debtors (Due After 1 year)00000000000000
Total Fixed Assets183,000477,000483,000431,000344,289356,346136,529109,93127,72847,78554,3623,6605,6985,141
Stock & work in progress427,000316,000289,000322,000304,346357,100206,881243,463172,041175,993135,46498,14787,85089,138
Trade Debtors879,000522,000569,000461,000388,097327,932313,491288,29825,33530,07933,034229,419247,851310,301
Group Debtors283,000675,000675,00000000000000
Misc Debtors97,00070,000124,00097,00035,31227,54932,06137,054302,699248,347202,529021,54215,305
Cash608,000754,000469,000444,000385,322199,016222,205116,71990,83166,96149,77210,76150,426139,036
misc current assets00000000000000
total current assets2,294,0002,337,0002,126,0001,324,0001,113,077911,597774,638685,534590,906521,380420,799338,327407,669553,780
total assets2,477,0002,814,0002,609,0001,755,0001,457,3661,267,943911,167795,465618,634569,165475,161341,987413,367558,921
Bank overdraft00000000000000
Bank loan00000000000000
Trade Creditors 361,000221,000372,000305,000246,570404,176303,363276,728457,805410,570329,606271,737308,951435,041
Group/Directors Accounts00000000000000
other short term finances000083,13393,08929,0560000000
hp & lease commitments00027,00026,92026,91900000000
other current liabilities1,468,0001,483,0001,670,0001,026,000317,081174,907148,119172,574000000
total current liabilities1,829,0001,704,0002,042,0001,358,000673,704699,091480,538449,302457,805410,570329,606271,737308,951435,041
loans00000000000000
hp & lease commitments0007,00033,35060,26800000000
Accruals and Deferred Income00000000000000
other liabilities00000000012,02632,981034,16653,630
provisions0035,00064,00044,70641,58321,59018,976000000
total long term liabilities0035,00071,00078,056101,85121,59018,976012,02632,981034,16653,630
total liabilities1,829,0001,704,0002,077,0001,429,000751,760800,942502,128468,278457,805422,596362,587271,737343,117488,671
net assets648,0001,110,000532,000326,000705,606467,001409,039327,187160,829146,569112,57470,25070,25070,250
total shareholders funds648,0001,110,000532,000326,000705,606467,001409,039327,187160,829146,569112,57470,25070,25070,250
Mar 2023Mar 2022Mar 2021Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Mar 2010
Operating Activities
Operating Profit-438,000518,000181,000271,000298,33074,475102,799207,42917,65643,85855,538-153-126-348
Depreciation241,000297,000354,000220,0003,8851,7662,50127,10426,31922,5936,7632,8241,8269,179
Amortisation000000000000043,605
Tax-25,00060,00029,000-96,000-55,969-13,596-20,463-41,589-3,791-10,154-13,365000
Stock111,00027,000289,00017,654-52,754150,219-36,58271,422-3,95240,52937,31710,29787,85089,138
Debtors-8,000-101,0001,368,000134,59167,9289,92920,200-2,68249,60842,8636,144-39,974269,393325,606
Creditors140,000-151,000372,00058,430-157,606100,81326,635-181,07747,23580,96457,869-37,214308,951435,041
Accruals and Deferred Income-15,000-187,0001,670,000708,919142,17426,788-24,455172,574000000
Deferred Taxes & Provisions0-35,00035,00019,2943,12319,9932,61418,976000000
Cash flow from operations-200,000576,000984,0001,029,398218,76350,091106,013134,67741,76353,86963,344-4,866-46,59272,733
Investing Activities
capital expenditure53,000-291,000-837,000-306,7118,172-221,583-29,099-109,307-6,262-16,016-57,465-786-7,524-57,925
Change in Investments00000000000000
cash flow from investments53,000-291,000-837,000-306,7118,172-221,583-29,099-109,307-6,262-16,016-57,465-786-7,524-57,925
Financing Activities
Bank loans00000000000000
Group/Directors Accounts00000000000000
Other Short Term Loans 000-83,133-9,95664,03329,0560000000
Long term loans00000000000000
Hire Purchase and Lease Commitments000-26,270-26,91787,18700000000
other long term liabilities00000000-12,026-20,95532,981-34,16634,16653,630
share issue00344,000-499,6060000000070,25070,250
interest1,0000-6,000-4,000-3,756-2,917-484519394292151153126348
cash flow from financing1,0000338,000-613,009-40,629148,30328,572519-11,632-20,66333,132-34,013104,542124,228
cash and cash equivalents
cash-146,000285,000469,00058,678186,306-23,189105,48625,88823,87017,18939,011-39,66550,426139,036
overdraft00000000000000
change in cash-146,000285,000469,00058,678186,306-23,189105,48625,88823,87017,18939,011-39,66550,426139,036

isopharm limited Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for isopharm limited. Get real-time insights into isopharm limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Isopharm Limited Competitor Analysis

BETA
competitor_analysis_table_img

Perform a competitor analysis for isopharm limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.

isopharm limited Ownership

ISOPHARM LIMITED group structure

Isopharm Limited has no subsidiary companies.

Ultimate parent company

ISOPHARM LIMITED

03843619

ISOPHARM LIMITED Shareholders

agilo software bidco limited 100%

isopharm limited directors

Isopharm Limited currently has 3 directors. The longest serving directors include Mr Paul Ward (Aug 2018) and Mr Neil Laycock (Jul 2023).

officercountryagestartendrole
Mr Paul WardUnited Kingdom47 years Aug 2018- Director
Mr Neil LaycockEngland55 years Jul 2023- Director
Mr James BodhaEngland57 years Apr 2024- Director

P&L

March 2023

turnover

5.6m

+4%

operating profit

-438k

-185%

gross margin

39.4%

-13.27%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

March 2023

net assets

648k

-0.42%

total assets

2.5m

-0.12%

cash

608k

-0.19%

net assets

Total assets minus all liabilities

isopharm limited company details

company number

03843619

Type

Private limited with Share Capital

industry

32500 - Manufacture of medical and dental instruments and supplies

incorporation date

September 1999

age

25

accounts

Full Accounts

ultimate parent company

None

previous names

isopharm sentry limited (May 2013)

sentry products limited (February 2005)

incorporated

UK

address

unit 18 jessops riverside, 800 brightside lane, sheffield, S9 2RX

last accounts submitted

March 2023

isopharm limited Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 6 charges/mortgages relating to isopharm limited. Currently there are 0 open charges and 6 have been satisfied in the past.

charges

isopharm limited Companies House Filings - See Documents

datedescriptionview/download